The Children’s Tumor Foundation’s Young Investigator Award (YIA) program is fueling breakthroughs in NF research. This year we invested $888,000 in 8 early-career scientists working on treatments for all forms of neurofibromatosis and schwannomatosis. These emerging researchers are exploring critical areas, including drug therapies for NF2-SWN, pain management, cutaneous neurofibromas, skeletal defects, and more. By supporting their work, we’re driving innovation, accelerating treatments, and ensuring a future with better options for all NF patients. |